novo nordisk oral semaglutide fda approval Approved to Reduce the Risk of Cardiovascular Events Novo asks FDA to prevent

If retatrutide reduces visceral fat, it may pull down elevated cortisol levels that often accompany excess

Deng YW, Shu YG, Sun SL

Yes, a 4 mm needle is suitable for almost all users regardless of body type

For someone who has been consistent with semaglutide but has hit a plateau or hasnt achieved their desired weight loss goals, transitioning to tirzepatide could offer a new pathway to progress

So how can benefits leaders address the rising health spend attributable to these medications

This topic is of particular interest to both healthcare professionals and patients, given the increasing use of semaglutide for managing obesity and type 2 diabetes